Edition:
United States

GW Pharmaceuticals PLC (GWPRF.PK)

GWPRF.PK on OTC Markets Group

13.56USD
24 Apr 2019
Change (% chg)

$0.01 (+0.07%)
Prev Close
$13.55
Open
$13.56
Day's High
$13.56
Day's Low
$13.56
Volume
819
Avg. Vol
5,005
52-wk High
$15.09
52-wk Low
$7.07

About

GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers... (more)
No analyst recommendations are available for .

Overall

Beta: 1.37
Market Cap(Mil.): £2,126.57
Shares Outstanding(Mil.): 25.37
Dividend: --
Yield (%): --

Financials

  GWPRF.PK Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -0.35 -- --
ROI: -38.35 8.91 13.83
ROE: -41.13 10.06 15.25

Earnings vs. Estimates